IL-6 expression induced by adenosine A2b receptor stimulation in U373 MG cells depends on p38 mitogen activated kinase and protein kinase C

[1]  M. Hüll,et al.  Serotonin via 5‐HT7 receptors activates p38 mitogen‐activated protein kinase and protein kinase C ɛ resulting in interleukin‐6 synthesis in human U373 MG astrocytoma cells , 2005, Journal of neurochemistry.

[2]  M. Hüll,et al.  1‐trichloromethyl‐1,2,3,4‐tetrahydro‐β‐carboline‐induced apoptosis in the human neuroblastoma cell line SK‐N‐SH , 2004, Journal of neurochemistry.

[3]  Wan-Wan Lin,et al.  PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP. , 2004, Cellular signalling.

[4]  C. Lang,et al.  Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity. , 2004, American journal of physiology. Endocrinology and metabolism.

[5]  B. Cronstein,et al.  Adenosine: an endogenous regulator of innate immunity. , 2004, Trends in immunology.

[6]  C. Szabó,et al.  ADENOSINE STIMULATES CREB ACTIVATION IN MACROPHAGES VIA A P38 MAPK‐MEDIATED MECHANISM: 165 , 2003 .

[7]  M. Merola,et al.  p38 MAPK is a critical regulator of the constitutive and the β4 integrin‐regulated expression of IL‐6 in human normal thymic epithelial cells , 2003, European journal of immunology.

[8]  B. Fredholm,et al.  The G(s)-coupled adenosine A(2B) receptor recruits divergent pathways to regulate ERK1/2 and p38. , 2003, Experimental cell research.

[9]  Edwin A. Deitch,et al.  cDNA Microarray Analysis Reveals a Nuclear Factor-κB-Independent Regulation of Macrophage Function by Adenosine , 2003, Journal of Pharmacology and Experimental Therapeutics.

[10]  J. Elias,et al.  Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. , 2003, The Journal of clinical investigation.

[11]  B. Fredholm,et al.  Adenosine A2B receptors modulate cAMP levels and induce CREB but not ERK1/2 and p38 phosphorylation in rat skeletal muscle cells , 2003 .

[12]  B. Fiebich,et al.  Valproic acid inhibits substance P‐induced activation of protein kinase C epsilon and expression of the substance P receptor , 2003, Journal of neurochemistry.

[13]  G. Wenk,et al.  The influence of brain inflammation upon neuronal adenosine A2B receptors , 2003, Journal of neurochemistry.

[14]  J. Schrader,et al.  Defining the Involvement of p38α MAPK in the Production of Anti- and Proinflammatory Cytokines Using an SB 203580-resistant Form of the Kinase* , 2003, Journal of Biological Chemistry.

[15]  M. Scanlon,et al.  Adenosine‐induced IL‐6 expression in pituitary folliculostellate cells is mediated via A2b adenosine receptors coupled to PKC and p38 MAPK , 2003, British journal of pharmacology.

[16]  Kazuhide Inoue.  Microglial activation by purines and pyrimidines , 2002, Glia.

[17]  P. Hasselgren,et al.  Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  T. Nakao,et al.  Role of mitogen‐activated protein kinase family in serum‐induced leukaemia inhibitory factor and interleukin‐6 secretion by bone marrow stromal cells , 2002, British journal of pharmacology.

[19]  M. Schwaninger,et al.  Interleukin-6 (IL-6): A Possible Neuromodulator Induced by Neuronal Activity , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[20]  M. Hastings,et al.  Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin , 2002, Nature Neuroscience.

[21]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[22]  David W. Anderson,et al.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Hüll,et al.  Mechanisms of prostaglandin E2‐induced interleukin‐6 release in astrocytes: possible involvement of EP4‐like receptors, p38 mitogen‐activated protein kinase and protein kinase C , 2001, Journal of neurochemistry.

[24]  J. Gutkind,et al.  G-protein-coupled receptors and signaling networks: emerging paradigms. , 2001, Trends in pharmacological sciences.

[25]  M. Poo,et al.  Binding of DCC by Netrin-1 to Mediate Axon Guidance Independent of Adenosine A2B Receptor Activation , 2001, Science.

[26]  H. Chae,et al.  Blockade of p38 mitogen-activated protein kinase pathway inhibits interleukin-6 release and expression in primary neonatal cardiomyocytes. , 2001, Research communications in molecular pathology and pharmacology.

[27]  H. Boddeke,et al.  Interleukin-6 Enhances Expression of Adenosine A1 Receptor mRNA and Signaling in Cultured Rat Cortical Astrocytes and Brain Slices , 2001, Neuropsychopharmacology.

[28]  G. Chrousos,et al.  The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. , 2000, Pharmacological reviews.

[29]  The Neuropeptide Substance P Activates p38 Mitogen-Activated Protein Kinase Resulting in IL-6 Expression Independently from NF-κB1 , 2000, The Journal of Immunology.

[30]  W. V. Berghe,et al.  Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. , 2000, Biochemical pharmacology.

[31]  A. Chédotal,et al.  Netrin-1-mediated axon outgrowth and cAMP production requires interaction with adenosine A2b receptor , 2000, Nature.

[32]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors , 2000 .

[33]  K. Klotz,et al.  Signaling by extracellular nucleotides and nucleosides , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[34]  Alexandre de Mendonça,et al.  Adenosine: does it have a neuroprotective role after all? , 2000, Brain Research Reviews.

[35]  B. Fredholm,et al.  Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. , 2000, Molecular pharmacology.

[36]  Wyeth Wasserman,et al.  Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[37]  M. Schwaninger,et al.  Adenosine‐induced expression of interleukin‐6 in astrocytes through protein kinase A and NF‐IL‐6 , 2000, Glia.

[38]  G. King,et al.  Identification of PKC-isoform-specific biological actions using pharmacological approaches. , 2000, Trends in pharmacological sciences.

[39]  E. Benveniste,et al.  Interleukin-6 expression and regulation in astrocytes , 1999, Journal of Neuroimmunology.

[40]  G. Haegeman,et al.  The Nuclear Factor-κB Engages CBP/p300 and Histone Acetyltransferase Activity for Transcriptional Activation of the Interleukin-6 Gene Promoter* , 1999, The Journal of Biological Chemistry.

[41]  C. Manthey,et al.  Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase , 1999, Inflammation Research.

[42]  J. Linden,et al.  Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. , 1999, Molecular pharmacology.

[43]  I. Biaggioni,et al.  Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. , 1999, Molecular pharmacology.

[44]  B. Fiebich,et al.  Carbamazepine-Induced Upregulation of Adenosine A1-Receptors in Astrocyte Cultures Affects Coupling to the Phosphoinositol Signaling Pathway , 1999, Neuropsychopharmacology.

[45]  K. Miyazawa,et al.  Regulation of Interleukin-1β-induced Interleukin-6 Gene Expression in Human Fibroblast-like Synoviocytes by p38 Mitogen-activated Protein Kinase* , 1998, The Journal of Biological Chemistry.

[46]  H. Przuntek,et al.  Short communication Interleukin‐6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease , 1998, Acta neurologica Scandinavica.

[47]  J. Bauer,et al.  Substance P and Histamine Induce Interleukin‐6 Expression in Human Astrocytoma Cells by a Mechanism Involving Protein Kinase C and Nuclear Factor‐IL‐6 , 1998, Journal of neurochemistry.

[48]  N. Rothwell,et al.  Cerebral Interleukin-6 is Neuroprotective during Permanent Focal Cerebral Ischemia in the Rat , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  I Biaggioni,et al.  Adenosine A2B receptors. , 1997, Pharmacological reviews.

[50]  S. Rose-John,et al.  Activation of gp 130 by IL‐6/soluble IL‐6 receptor induces neuronal differentiation , 1997, The European journal of neuroscience.

[51]  M. Mirabet,et al.  Calcium mobilization in Jurkat cells via A2b adenosine receptors , 1997, British journal of pharmacology.

[52]  S. Ferroni,et al.  Protective Mechanisms of Adenosine in Neurons and Glial Cells a , 1997, Annals of the New York Academy of Sciences.

[53]  Markus Schwaninger,et al.  Stimulation of Interleukin‐6 Secretion and Gene Transcription in Primary Astrocytes by Adenosine , 1997, Journal of neurochemistry.

[54]  U. Otten,et al.  Interleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials , 1997, Progress in Neurobiology.

[55]  Knut Biber,et al.  Adenosine A1 Receptor-Mediated Activation of Phospholipase C in Cultured Astrocytes Depends on the Level of Receptor Expression , 1997, The Journal of Neuroscience.

[56]  Y. Nomura,et al.  Protein kinase A-dependent IL-6 production induced by calcitonin in human glioblastoma A172 cells , 1997, Journal of Neuroimmunology.

[57]  C. Heyser,et al.  Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Hüll,et al.  Prostaglandin E2 Induces Interleukin‐6 Synthesis in Human Astrocytoma Cells , 1997, Journal of neurochemistry.

[59]  M. Gschwendt,et al.  Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymes , 1996 .

[60]  H. Kiyama,et al.  Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma , 1996, The Journal of experimental medicine.

[61]  J. Bauer,et al.  Interleukin‐1β Uses Common and Distinct Signaling Pathways for Induction of the Interleukin‐6 and Tumor Necrosis Factor α Genes in the Human Astrocytoma Cell Line U373 , 1996 .

[62]  J. Bauer,et al.  Adenosine A2b Receptors Mediate an Increase in Interleukin (IL)‐6 mRNA and IL‐6 Protein Synthesis in Human Astroglioma Cells , 1996, Journal of neurochemistry.

[63]  J. Westwick,et al.  Interleukin-1-induced IL-8 and IL-6 gene expression and production in human mesangial cells is differentially regulated by cAMP. , 1995, Kidney international.

[64]  P. Musiani,et al.  IL‐6 Expression in Neurons of Transgenic Mice Causes Reactive Astrocytosis and Increase in Ramified Microglial Cells but no Neuronal Damage , 1995, The European journal of neuroscience.

[65]  F. Urbani,et al.  Interleukin-6 production by U373 MG, a human astrocytoma cell line: different pathways involved in substance P and lipopolysaccharide activation , 1995, Journal of Neuroimmunology.

[66]  E. Cadman,et al.  cAMP is not involved in interleukin-1-induced interleukin-6 release from human astrocytoma cells , 1994, Neuroscience Letters.

[67]  E. Cadman,et al.  Regulation of the Release of Interleukin‐6 from Human Astrocytoma Cells , 1994, Journal of neurochemistry.

[68]  B. Fredholm,et al.  Adenosine A2B receptor signalling is altered by stimulation of bradykinin or interleukin receptors in astroglioma cells , 1994, Neurochemistry International.

[69]  J. Murray,et al.  Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells. , 1994, Molecular pharmacology.

[70]  F. Marks,et al.  Rottlerin, a novel protein kinase inhibitor. , 1994, Biochemical and biophysical research communications.

[71]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[72]  B. Rabin,et al.  Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness , 1994, Psychiatry Research.

[73]  P. Parker,et al.  Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. , 1993, The Biochemical journal.

[74]  G. Martiny-Baron,et al.  Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. , 1993, The Journal of biological chemistry.

[75]  H. Hug,et al.  Protein kinase C isoenzymes: divergence in signal transduction? , 1993, The Biochemical journal.

[76]  M. W. Flye,et al.  Prostaglandin E2 downregulates Kupffer cell production of IL-1 and IL-6 during hepatic regeneration. , 1993, The American journal of physiology.

[77]  T. Abrams,et al.  cAMP modulates multiple K+ currents, increasing spike duration and excitability in Aplysia sensory neurons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[78]  J. Bauer,et al.  Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[79]  J. Bauer,et al.  The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. , 1992 .

[80]  K. Albermann,et al.  Nuclear Factor Kb: An Oxidative Stress-Responsive Transcription Factor of Eukaryotic Cells (A Review) , 1992 .

[81]  H. Coste,et al.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. , 1991, The Journal of biological chemistry.

[82]  H. Yagisawa,et al.  IL1 induces proliferation and IL6 mRNA expression in a human astrocytoma cell line: positive and negative modulation by chorela toxin and cAMP. , 1990, Biochemical and biophysical research communications.

[83]  J. Vilček,et al.  Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. , 1988, The Journal of biological chemistry.

[84]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[85]  Margarete Müller,et al.  ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLS , 1979, Journal of neurochemistry.

[86]  Margarete Müller,et al.  Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells , 1978, Nature.

[87]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.